Allergic rhinitis
Conditions
Interventions
Queue 3(Western medicine + Chinese patent medicine (mainly including Yiqi Tongqiao Pills)):None
Queue 1(Western medicine * (such as antihistamines, nasal hormones, etc.)):None
Queue 2(Chinese patent medicines (mainly including Yiqi Tongqiao Pills)):None
Sponsors
Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age 18 years old and above, gender not limited; 2.Diagnosed by a clinical doctor as allergic rhinitis; 3.One or more allergens tested positive (such as pollen, fungi, etc.), with a positive result for skin prick test (2+ or above), or a positive result for any allergen in the serum allergen test (results from the past 12 months are acceptable); 4.The clinical doctor prescribes Western medicine or Chinese patent medicine prescriptions based on their usual clinical practice for treatment. 5.Voluntary signing of the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients with nasal polyps, acute sinusitis, upper respiratory tract infection, nasal tumors, and severe deviation of the nasal septum will be included; 2.Severe heart and lung diseases, serious blood system disorders, or other severe diseases that threaten the patient's life, such as malignant tumors, etc; 3.Those who are allergic to the drug ingredients/formulation; 4.Have been participating in other interventional clinical studies within the past three months; 5.The researchers considered themselves ineligible to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Effectiveness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total nasal symptom score (TNSS) score;Visual analogue scale (VAS); | — |
Countries
China
Contacts
Public ContactCheng Lei
Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Outcome results
None listed